Cardiogenic Shock in Non-Ischemic Cardiomyopathy: Dynamic Mechanical Circulatory Support and Pathophysiology Illustration

Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102126. doi: 10.1016/j.cpcardiol.2023.102126. Epub 2023 Oct 5.

Abstract

Nonischemic cardiomyopathy (NICM) is a significant cause of cardiogenic shock (CS). We present a case of a 56-year-old previously healthy man who arrived with vague abdominal symptoms, over 2 weeks. Subsequently, the patient's condition rapidly deteriorated over 12 hours, leading to cardiogenic shock categorized as Society for Cardiovascular Angiography and Interventions (SCAI) stage D. Echocardiography and right heart catheterization confirmed multiorgan failure secondary to severe cardiac dysfunction. Mechanical circulatory support was initiated using an Impella CP device 20 hours after admission due to ongoing deterioration. Considering refractory cardiogenic shock and within 24 hours, the patient received combined veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and Impella CP support (ECPElla). With gradual improvement in the patient's clinical status and organ function, successful weaning from VA ECMO to Impella 5.5 was achieved. Ultimately, the patient underwent a successful orthotopic heart and kidney transplantation, marking a significant milestone in his recovery. The case underscores the importance of promptly identifying and responding to cardiogenic shock through invasive hemodynamic assessment. Collaborative decision-making involving a multidisciplinary team played a crucial role in the initiation, escalation, and eventual weaning of mechanical circulatory support, culminating in the successful bridging to a dual organ transplantation for this patient with CS secondary to NICM.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Cardiomyopathies* / complications
  • Cardiomyopathies* / therapy
  • Extracorporeal Membrane Oxygenation* / adverse effects
  • Heart Diseases*
  • Heart Failure* / complications
  • Heart Failure* / therapy
  • Heart-Assist Devices* / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / therapy